| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40aa3605f78a3d9cb44895771685ec90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de3443dcbd24223a58228a411b8b150d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_338e0f7662c51c438bb348fdf989d09c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ba9216d31932815686bddfd2aa27a8 |
| publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018085435-A1 |
| titleOfInvention |
Use of Long-Acting GLP-1 Peptides |
| abstract |
The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114796462-A |
| priorityDate |
2012-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |